<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22-pharmaceuticals-12-00101">
 <label>22.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Musso</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Nhan</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Robin</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Roche</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bierlaire</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Zisou</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Shan Yan</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cao-Lormeau</surname>
    <given-names>V.M.</given-names>
   </name>
   <name>
    <surname>Broult</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014</article-title>
  <source>Eurosurveillance</source>
  <year>2014</year>
  <volume>19</volume>
  <pub-id pub-id-type="doi">10.2807/1560-7917.ES2014.19.14.20761</pub-id>
  <?supplied-pmid 24739982?>
  <pub-id pub-id-type="pmid">24739982</pub-id>
 </element-citation>
</ref>
